Touyun Biotech Group Limited is a publicly listed company on the Hong Kong Stock Exchange Main Board (Stock Code: 01332) specializing in biotechnology, packaging solutions, and marketing technology. The company operates multiple business divisions including Chlamydomonas Reinhardtii health products, high-quality packaging manufacturing, QR code-based marketing solutions, and financial investment services. As a listed entity serving both B2B clients and retail consumers, Touyun Biotech required a sophisticated corporate website that effectively communicates their diverse business portfolio while meeting regulatory requirements for investor relations and corporate governance disclosure.
DOOD Limited delivered a comprehensive digital solution combining website design and WordPress development services specifically tailored for publicly listed biotechnology operations. The project centered on creating a professional corporate platform that serves multiple stakeholder audiences including investors, business partners, consumers, and regulatory bodies.Our team executed complete web UX design optimization focused on corporate governance standards and user journey mapping across distinct audience segments. The design balances investor relations requirements with product showcase needs, ensuring shareholders can access financial reports and announcements while potential clients explore Chlamydomonas Reinhardtii health products, packaging solutions, and QR technology marketing services.The platform architecture supports multilingual functionality across English, Traditional Chinese, and Simplified Chinese, recognizing Touyun Biotech's operations spanning Hong Kong, Mainland China, and international markets. This strategic multilingual approach ensures comprehensive market coverage while meeting regulatory requirements for corporate communications in multiple languages, essential for listed companies serving diverse investor bases across different regions.
Built on a robust WordPress foundation with custom development, the platform features sophisticated information architecture organizing content across group profile, business divisions, investor relations, press centre, and contact sections. The responsive design ensures consistent presentation across all devices, critical for investors accessing financial reports and shareholders reviewing announcements from various platforms and locations.We implemented WPML (WordPress Multilingual) integration for seamless language switching across English, Traditional Chinese, and Simplified Chinese versions, ensuring content accuracy and regulatory compliance across all language variants. The investor relations section features dedicated areas for corporate information, announcements, financial reports, corporate governance documentation, shareholder communications, and stock information—meeting Hong Kong Stock Exchange disclosure requirements.Advanced content management capabilities enable the internal team to publish time-sensitive announcements, update financial reports, share industry news, and maintain product information across multiple business divisions. The technical implementation prioritizes security protocols protecting sensitive corporate information, fast loading speeds for document access, and reliable performance essential for maintaining credibility with institutional investors and regulatory bodies. Clear navigation pathways guide different user segments toward relevant sections whether seeking investment information, product details, or business partnership opportunities.
We provide continuous WordPress maintenance services, ensuring Touyun Biotech's corporate platform remains secure, compliant, and fully operational for all stakeholder audiences. Our maintenance package includes regular security updates, performance optimization, plugin compatibility management, content updates across three language versions, and comprehensive backup protocols protecting valuable corporate information, financial documentation, and regulatory filings.The platform benefits from our high-performance hosting services, delivering consistent uptime critical for a listed company requiring 24/7 access to investor relations materials and corporate announcements. We conduct ongoing monitoring to ensure optimal performance during market hours and peak investor activity periods, particularly during earnings announcements and financial report releases.Our proactive maintenance approach includes automated backups, server optimization, security hardening for corporate data protection, and rapid technical support response to maintain uninterrupted operations. Regular multilingual content updates, regulatory document publications, and technical adjustments are handled efficiently through our maintenance services, allowing Touyun Biotech's team to focus on business operations and investor relations while we manage their critical digital infrastructure across all three language versions.
Touyun Biotech Group Limited now operates a sophisticated multilingual corporate platform that effectively serves their diverse stakeholder base while meeting regulatory requirements for publicly listed companies in Hong Kong. The website successfully balances investor relations functionality with product showcase capabilities, providing shareholders with transparent access to financial information while enabling business development through comprehensive presentation of their biotechnology products, packaging solutions, and marketing technology services. The platform's robust architecture, multilingual support, and stable performance infrastructure support Touyun Biotech's continued growth as a listed entity operating across biotechnology, manufacturing, and technology sectors throughout Greater China and international markets.
